Swiss investor HBM leads funding in TPG-backed drugmaker at $1.65 bn valuation
Stay Home. Read Quality News
Advertisement
  • Home
  • Healthcare
  • Swiss investor HBM leads funding in TPG-backed drugmaker at $1.65 bn valuation

Swiss investor HBM leads funding in TPG-backed drugmaker at $1.65 bn valuation

By Roshan Abraham

  • 16 Oct 2024
Premium
Swiss investor HBM leads funding in TPG-backed drugmaker at $1.65 bn valuation
Credit: 123RF.com

Swiss investment firm HBM Healthcare has led a Rs 801 crore ($95 million) funding round in an Indian contract drug .........

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Become a Premium member
Already a member? Click here to log in.
Advertisement

Related Articles

Premium
Gujarat Superspeciality Hospital eyes acquisition-led growth in western India

Healthcare

Gujarat Superspeciality Hospital eyes acquisition-led growth in western India

PE-backed Indira IVF and listed MosChip strike M&A deals

Healthcare

PE-backed Indira IVF and listed MosChip strike M&A deals

Premium
PAG eyes exit from healthcare portfolio firm, hires banker

Healthcare

PAG eyes exit from healthcare portfolio firm, hires banker

Pro
Aakash Healthcare nears deal to bring in PE investor

Healthcare

Aakash Healthcare nears deal to bring in PE investor

Pro
Motilal Oswal Alts gets an exit from decade-old bet with below-par returns

Healthcare

Motilal Oswal Alts gets an exit from decade-old bet with below-par returns

Premium
KKR-controlled Healthcare Global looks to expand footprint, weighs M&A

Healthcare

KKR-controlled Healthcare Global looks to expand footprint, weighs M&A

Everstone to invest $270 mn in drugmaker Apothecon

Healthcare

Everstone to invest $270 mn in drugmaker Apothecon

Advertisement
Google News Icon

Google News

Follow VCCircle on Google News for the latest updates on Business and Startup News

FOLLOW